Product Name :
Anti-CD254/RANKL(Denosumab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human TNFSF11/CD254/RANKL/TRANCE/OPGL/ODF
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-CD254/RANKL(Denosumab Biosimilar) Antibody is a biosimilar antibody directed against Human TNFSF11/CD254/RANKL/TRANCE/OPGL/ODF. | Isotype: Human IgG2 | Conjugate: Unconjugated | Specificity: Human TNFSF11/CD254/RANKL/TRANCE/OPGL/ODF | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-CD254/RANKL(Denosumab Biosimilar) Antibody is a biosimilar antibody directed against Human TNFSF11/CD254/RANKL/TRANCE/OPGL/ODF.
Immunogen:
Host :
Isotype:
Human IgG2
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.{{852391-15-2} web|{852391-15-2} Biological Activity|{852391-15-2} In Vivo|{852391-15-2} supplier} Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc.{{4547-24-4} MedChemExpress|{4547-24-4} Biological Activity|{4547-24-4} References|{4547-24-4} supplier} The actual dilution used must be determined empirically.PMID:31194406